Rusan Medisys Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 38.40%
- Profit Growth 32.48%
- Ebitda 22.96%
- Net Worth 96.95%
- Total Assets 167.40%
About Rusan Medisys
Rusan Medisys Private Limited (RMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 May 2008 and has a history of 16 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharath Tolia, Komal Ghelani, and Sushilkumar Zatakia serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U72900MH2008PTC182924
-
Company No.
182924
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 May 2008
-
Date of AGM
29 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Rusan Medisys?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharath Tolia
|
Director | 09-Jan-2009 | Current |
|
Komal Ghelani
|
Director | 22-Aug-2018 | Current |
|
Sushilkumar Zatakia
|
Director | 30-May-2008 | Current |
Financial Performance of Rusan Medisys.
Rusan Medisys Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.4% increase. The company also saw a substantial improvement in profitability, with a 32.48% increase in profit. The company's net worth Soared by an impressive increase of 96.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rusan Medisys?
Unlock access to Rusan Medisys's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rusan Medisys?
Rusan Medisys has a workforce of 168 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rusan Medisys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rusan Medisys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
